Launching a new product in a packed pharmaceutical market requires an incisive marketing strategy. Learn more here: ...
Healthcare is moving its focus from the quantity of real-world data (RWD) to quality, with targeted AI a key tool. We explore ...
Multiple big pharma companies are reported to be circling Revolution, a cancer biotech with a market cap of $23bn.
AbbVie's deal with RemeGen is the first to be announced during the 2026 J.P Morgan Healthcare Conference, with more deals ...
A new co-innovation lab in the San Francisco Bay area will see Lilly and NVIDIA scientists work alongside each other to fuel ...
MediLink Therapeutics has signed an exclusive licensing agreement with Roche for the development and commercialisation of ...
Clinical and commercial quality controls are eased as the FDA looks to expedite therapy approvals in areas of unmet need.
Novartis has announced plans to construct a new US radioligand therapy (RLT) manufacturing facility in Winter Park, Florida.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback